CG

The Carlyle Group
NASDAQ

Real-time Quotes | Nasdaq Last Sale

23.57
-0.50
-2.08%
After Hours: 23.57 0 0.00% 16:45 09/24 EDT
OPEN
24.15
PREV CLOSE
24.07
HIGH
24.15
LOW
23.48
VOLUME
877.05K
TURNOVER
--
52 WEEK HIGH
34.98
52 WEEK LOW
15.21
MARKET CAP
8.22B
P/E (TTM)
-27.0360
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
P&G Will Rename Skin Creams ‘at Minimum’: Equality Summit Update
Procter & Gamble Co. Chief Brand Officer Marc Pritchard wouldn’t say the company would stop selling controversial skin lightening creams that have come under scrutiny for perpetuating harmful racial stereotypes. “At a minimum,” though, the consumer products giant will rename them. Kewsong Lee, co-chief executive officer of Carlyle Group, said that his company has not had an issue finding diverse talent.
Bloomberg · 1d ago
Carlyle Group CEO Lee on Creating Inclusive Culture
The Carlyle Group Chief Executive Officer Kewsong Lee talks about creating a more diverse and inclusive culture with Bloomberg’s Sonali Basak at the Bloomberg Equality Summit virtual event. (Source: Bloomberg)
Bloomberg · 1d ago
Carlyle Co-Founder Says U.S.-China Relations at Lowest Since ‘89
(Bloomberg) -- Carlyle Group Inc. co-founder David Rubenstein said U.S.-China relations are at their lowest since the 1989 Tiananmen crackdown, but are likely to improve after the U.S. elections.Rubenstein is the latest to weigh in on tensions between the two countries, which companies including TikTok
Bloomberg · 2d ago
Carlyle Makes Strategic Growth Investment in TriNetX; Acquires Majority Stake in Leading Global Health Research Network
TriNetX (www.trinetx.com), the leading global health research network optimizing clinical research to bring new therapies to market faster, today announced global investment firm The Carlyle Group (NASDAQ: CG) has made a strategic growth investment and will acquire a majority stake in the Company. Terms
PR Newswire · 3d ago
Carlyle Group invests in health research network TriNetX
Carlyle Group ([[CG]] -1.9%) makes an investment in TriNetX, a health research network that aims to optimize clinical research to bring new therapies to market faster, and will acquire a majority
Seekingalpha · 3d ago
Carlyle to Acquire Data Company TriNetX in Health-Care Drive
(Bloomberg) -- Carlyle Group Inc., the alternative asset manager overseeing $221 billion, is buying a majority stake in clinical data company TriNetX Inc.Equity capital for the investment came from the $18.5 billion private equity fund, Carlyle Partners VII, the company said Monday, declining to comment
Bloomberg · 3d ago
How Covid-19 Permanently Changed the Way Businesses Operate
The Covid-19 pandemic has permanently changed how businesses operate, according to a report from the Carlyle Group.
Barrons.com · 6d ago
A Deep Dive Into ZoomInfo -- the Other Cool "Zoom" Company
MotleyFool.com · 09/17 11:24
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CG. Analyze the recent business situations of The Carlyle Group through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 15 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CG stock price target is 30.93 with a high estimate of 40.00 and a low estimate of 27.00.
EPS
Institutional Holdings
Institutions: 364
Institutional Holdings: 115.81M
% Owned: 33.21%
Shares Outstanding: 348.69M
TypeInstitutionsShares
Increased
62
14.23M
New
126
25.67M
Decreased
58
7.89M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Investment Management & Fund Operators
-0.85%
Investment Banking & Investment Services
+0.14%
Key Executives
Co-Chairman/Founder/Director
William Conway
Co-Chairman/Founder/Director
David Rubenstein
Non-Executive Chairman/Founder
Daniel D' Aniello
Co-Chief Executive Officer/Director
Kewsong Lee
Co-Chief Executive Officer/Director
Glenn Youngkin
Chief Financial Officer
Curtis Buser
Chief Operating Officer
Christopher Finn
Chief Investment Officer/Director
Peter Clare
Chief Human Resource Officer
Bruce Larson
General Counsel
Jeffrey Ferguson
Other/Director
James Hance
Independent Director
Lawton Fitt
Independent Director
Janet Hill
Other
Kara Helander
Independent Director
Thomas Robertson
Other
Long Hoang
Independent Director
William Shaw
Independent Director
Anthony Welters
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
07/23/2020
Dividend USD 0.25
08/10/2020
04/23/2020
Dividend USD 0.25
05/11/2020
02/04/2020
Dividend USD 0.25
02/14/2020
10/24/2019
Dividend USD 0.31
11/08/2019
07/30/2019
Dividend USD 0.43
08/09/2019
04/24/2019
Dividend USD 0.19
05/10/2019
02/05/2019
Dividend USD 0.43
02/15/2019
10/24/2018
Dividend USD 0.42
11/09/2018
07/25/2018
Dividend USD 0.22
08/10/2018
04/25/2018
Dividend USD 0.27
05/10/2018
02/06/2018
Dividend USD 0.33
02/16/2018
10/24/2017
Dividend USD 0.56
11/09/2017
08/01/2017
Dividend USD 0.42
08/10/2017
04/26/2017
Dividend USD 0.1
05/11/2017
02/07/2017
Dividend USD 0.16
02/16/2017
10/25/2016
Dividend USD 0.5
11/04/2016
07/26/2016
Dividend USD 0.63
08/11/2016
04/26/2016
Dividend USD 0.26
05/12/2016
02/09/2016
Dividend USD 0.29
02/19/2016
10/27/2015
Dividend USD 0.56
11/12/2015
07/28/2015
Dividend USD 0.89
08/17/2015
04/28/2015
Dividend USD 0.33
05/13/2015
02/10/2015
Dividend USD 1.61
02/19/2015
10/28/2014
Dividend USD 0.16
11/06/2014
07/29/2014
Dividend USD 0.16
08/07/2014
04/29/2014
Dividend USD 0.16
05/12/2014
02/18/2014
Dividend USD 1.4
02/27/2014
11/05/2013
Dividend USD 0.16
11/14/2013
08/06/2013
Dividend USD 0.16
08/15/2013
05/08/2013
Dividend USD 0.16
05/16/2013
02/20/2013
Dividend USD 0.85
02/28/2013
11/06/2012
Dividend USD 0.16
11/15/2012
08/07/2012
Dividend USD 0.11
08/16/2012
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About CG
The Carlyle Group Inc., formerly The Carlyle Group L.P., is a diversified multi-product global alternative asset management firm. The Company advises on various investment funds and other investment vehicles that invests across a range of industries, geographies, asset classes and investment strategies, and seeks to deliver returns for its fund investors. The Company operates in four segments: Corporate Private Equity (CPE), Real Assets, Global Credit and Investment Solutions. The Corporate Private Equity segment is comprised of the operations that advise a diverse group of funds that invest in buyout, middle market and growth capital transactions that focus on either a geography or a particular industry. The Real Assets segment is comprised of the operations that advise United States and international funds focused on real estate, infrastructure, energy and renewable energy transactions.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Carlyle Group Inc stock information, including NASDAQ:CG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CG stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CG stock methods without spending real money on the virtual paper trading platform.